表紙
市場調查報告書

全球重點照護(POC)傳染病檢查市場新境界:商務課題,新技術,競爭環境

2019 POC Infectious Disease Testing Market: Reagent and Instrument Supplier Shares, Sales Segment Forecasts for 100 Tests, Emerging Technologies, Instrumentation Review, Competitive Landscape, Opportunities for Suppliers

出版商 Venture Planning Group 商品編碼 304988
出版日期 內容資訊 英文 835 Pages
商品交期: 最快1-2個工作天內
價格
全球重點照護(POC)傳染病檢查市場新境界:商務課題,新技術,競爭環境 2019 POC Infectious Disease Testing Market: Reagent and Instrument Supplier Shares, Sales Segment Forecasts for 100 Tests, Emerging Technologies, Instrumentation Review, Competitive Landscape, Opportunities for Suppliers
出版日期: 內容資訊: 英文 835 Pages
簡介

本報告提供全球主要國家(美國·德國·西班牙)的重點照護(POC的)傳染病檢查的市場現狀·未來展望相關分析,提供相關技術及市場(檢驗試劑·試劑等)的最新情形,及各國·各部門的市場規模及成長率(今後5年份),法規環境,競爭結構,今後的需求·技術活用方法的方向性,及主要企業簡介等調查。

簡介

摘要整理

分散式檢查產品的合理的根據

全球技術·市場概況

  • AIDS
  • 腺病毒
  • 曲狀桿菌症
  • 念珠菌
  • 披衣菌感染
  • 困難腸梭菌
  • 巨細胞病毒
  • 腸病毒
  • Epstein-Barr(EB)病毒
  • 淋病
  • 幽門螺桿菌胃幽門桿菌
  • 肝炎
  • 單純皰疹病毒
  • 人類第六型皰疹病毒(HHV-6)
  • 流感病毒
  • 退伍軍人菌
  • 萊姆病
  • 麻疹
  • 腦膜炎
  • 單核症
  • 腮腺炎
  • 霉漿菌屬
  • 乳突狀病毒
  • 肺炎
  • 呼吸道融合瘤病毒(RSV)
  • 風濕性關節炎
  • 輪狀病毒(利奧病毒)
  • 德國麻疹
  • 沙門菌
  • 赤痢菌
  • 黃色葡萄球菌
  • 鏈球菌
  • 梅毒
  • 傳染病檢查用分析設備(Abbott,Beckman Coulter/Danaher,bioMeriuex,Ortho-Clinical Diagnostics,Roche,Siemens,Tosoh,Wallac另外)

現在·未來的技術

  • 單株抗體
  • 流行病學的審定
  • 乾式化學分析
  • 生物感應器
  • IT·自動化
  • 分子診斷

美國市場

  • 市場概況
    • 商務環境
    • 市場結構
  • 開業醫生·聯合診療
  • 輔助的醫療設備
  • 癌症診所
  • 門診病人治療中心
  • 外科手術中心
  • 看護設備
  • 產院
  • 主要供應商的設備配置方法,裝機率(用戶數),檢查裝置·消耗品的銷售額·市場佔有率

德國市場

  • 商務環境
  • 市場結構
  • 市場概況
  • 檢查數量·銷售額預測
  • 主要供應商的設備配置方法,裝機率(用戶數),檢查裝置·消耗品的銷售額·市場佔有率

西班牙市場

  • 商務環境
  • 市場結構
  • 市場概況
  • 檢查數量·銷售額預測
  • 主要供應商的設備配置方法,裝機率(用戶數),檢查裝置·消耗品的銷售額·市場佔有率

產品開發主要的機會

分散式檢查產品的設計標準

替代性的市場普及策略

  • 內部開發
  • 合資企業協定
  • 與大學的契約
  • 分散式檢查市場流通策略
    • 行銷的方法
    • 產品的複雜性
    • 客戶的偏好
    • 既有廠商
    • 新加入廠商
    • 主要種類的流通業者
    • 市場分類

加入市場的潛在障礙與風險

  • 市場的成熟度
  • 成本控制
  • 競爭
  • 技術的限制
  • 專利保護
  • 法規的限制
  • 分散檢驗市場課題

競爭企業簡介

  • Abbott
  • Affymetrix
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • bioMerieux
  • Bio-Rad
  • Cepheid
  • Diamedix
  • DiaSorin
  • 榮研化學
  • Enzo Biochem
  • FUJIREBIO/Innogenetics
  • Grifols/Novartis Diagnostics
  • Hologic/Gen-Probe
  • ID Biomedical/GSK
  • Kreatech
  • Lonza
  • Nanogen/Elitech
  • Ortho-Clinical Diagnostics
  • Qiagen
  • Roche
  • Scienion
  • Sequenom
  • SeraCare
  • Siemens
  • TaKaRa BIO
  • Thermo Fisher/Life Technology
  • Wallac/PE
  • 和光純藥工業

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: VPPOC39260

VPGMarketResearch’s new report provides comprehensive analysis of the  POC infections disease testing market, including its dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers.

Rationale

The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient.

Market Segmentation

- Review of the POC market segments, including their dynamics, trends, structure, size, growth and major suppliers.

- Five-year test volume and reagent sales forecasts for major infectious disease tests by market segment:
Physician Offices/Group Practices Emergency Rooms Ambulatory Care Centers Surgery Centers Birth Centers

Sales and Market Share Analysis

- Sales and market shares of major reagent and instrument suppliers.

Infectious Disease Tests

AIDS/HIV, Adenovirus, Aeromonads, Bartonella, Blastocystis Hominis, Campylobacter, Candida, Chancroid, Chlamydia, Clostridium, Coronavirus, Coxsackievirus, Cryptosporidium, Cyclospora, CMV, E. Coli, Echovirus,  Encephalitis, Enterovirus, EBV, Giardia, Gonorrhea, Granuloma Inguinale, Hantavirus, H. Pylori, Hepatitis (A, B, C, D, E), Herpes Simplex Virus, Human Herpes Virus-6 (HHV-6), Influenza, Legionella, Lyme disease, Pymphogranuloma, Malaria, Measles, Meningitis, Mononucleosis, Microsporidium, Mononucleosis, Mumps, Mycoplasma, Polyomaviruses, Parvovirus B19, Pneumonia, Polyomaviruses, Pseudomonas, Rabies, RSV, Rhinovirus, Rheumatoid Arthritis, Rotavirus , Rubella, Salmonellosis, Septicemia, Shigella, Staphylococci, Streptococci, Syphilis, Toxoplasmosis, Trichomonas, Tuberculosis, Vibrio, West Nile, Yersenia.

Technology Review

- Emerging technologies and their applications for POC testing. Comprehensive listings of companies developing or marketing POC diagnostic technologies and products, by test.

Strategic Recommendations

- Specific opportunities for new POC instruments and reagent systems with potentially significant market appeal during the next five years. Design criteria for POC testing products. Alternative business expansion strategies. Potential market entry barriers and risks.

Competitive Assessments

- Assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, joint ventures, and new products in R&D.

- The companies analyzed in the report include:

Abbott Accriva Agilent Technologies Axis-Shield Beckman Coulter/Danaher Becton Dickinson Bio/Data bioMerieux Bio-Rad Cepheid Chrono-Log Corgenix Decode Genetics Diagnostica Stago Diamedix DiaSorin Eiken Chemical EKF Diagnostics Fujirebio Grifols Helena Laboratories Hologic Horiba Instrumentation Laboratory/Werfen Kyowa Medex Leica Biosystems Lonza Nihon Kohden Ortho-Clinical Diagnostics Polymedco Qiagen Roche SDIX Sekisui Diagnostics Sequenom Siemens Healthineers Sienco Sysmex Takara Bio Thermo Fisher Tosoh Wako

Methodology

This report is based on a combination of primary and secondary sources of information, including review of recent technical and business publications, manufacturer product literature, industry analyst reports, and VPGMarketResearch's proprietary data files.

Contains 835 pages and 80 tables

Table of Contents

Introduction

Executive Summary

Rationale for Testing Decentralization

  • 1. Overview
  • 2. Regulatory Trends
  • 3. Economic Trends
  • 4. Demographic Trends
  • 5. Technological Trends
  • 6. Social Trends
  • 7. Quality of Care
  • 8. Defensive Medicine
  • 9. Quality Control Issues

Worldwide Market and Technology Overview

  • 1. AIDS
  • 2. Adenovirus
  • 3. Campylobacter
  • 4. Candida
  • 5. Chlamydia
  • 6. Clostridium Difficile
  • 7. Cytomegalovirus
  • 8. Enteroviruses
  • 9. Epstein-Barr Virus
  • 10. Gonorrhea
  • 11. Helicobacter Pylori
  • 12. Hepatitis
    • a. Hepatitis A
    • b. Hepatitis B
    • c. Hepatitis C
    • d. Hepatitis D
  • 13. Herpes Simplex Virus
  • 14. Human Herpes Virus-6 (HHV-6)
  • 15. Influenza Viruses
  • 16. Legionella
  • 17. Lyme Disease
  • 18. Measles (Rubeola)
  • 19. Meningitis
  • 20. Mononucleosis
  • 21. Mumps
  • 22. Mycoplasma
  • 23. Papillomaviruses
  • 24. Pneumonia
  • 25. Respiratory Syncytial Virus (RSV)
  • 26. Rheumatoid Arthritis
  • 27. Rotavirus (Reovirus)
  • 28. Rubella (German Measles)
  • 29. Salmonellosis
  • 30. Shigellosis
  • 31. Staphylococcus Aureus
  • 32. Streptococci
  • 33. Syphilis
  • Instrumentation: Infectious Disease Analyzers Manufactured by:
  • Abbott
  • Beckman Coulter/Danaher
  • bioMeriuex
  • Ortho-Clinical Diagnostics
  • Roche
  • Siemens
  • Tosoh
  • Wallac, and other suppliers

Current and Emerging Technologies

  • 1. Monoclonal Antibodies
  • 2. Immunoassays
    • a. Technological Principle
    • b. Enzyme Immunoassays (EIA)
    • Overview
    • ELISA
    • Dot Immunobinding Assays
    • Capillary Immunoassays
    • Particle-Membrane Capture Immunoassay
    • Enzyme Amplification
  • c. Fluorescent Immunoassays
    • Fluorescent Polarization
    • Time-Resolved Pulse Fluorescence
  • d. Luminescence
    • Chemiluminescence
    • Bioluminescence
    • e. Latex Agglutination
    • f. Immunoprecipitation
  • 3. Dry Chemistry
  • 4. Biosensors
  • 5. IT and Automation
  • 6. Molecular Diagnostics
    • a. Technology Overview
    • b. Amplification Methods
      • Polymerase Chain Reaction
      • Ligase Chain Reaction
      • Branched DNA
      • Q-Beta Replicase
      • Strand Displacement Activation
      • Self-Sustained Sequence Replicase

U.S.A.

  • A. Market Overview
    • 1. Business Environment
      • a. Health Care Expenditures
      • b. Cost Consciousness
      • c. Reimbursement
      • d. Industry Consolidation
      • e. Managed Care
        • PPO
        • HMO
      • f. Hospitals
      • g. Admissions
      • h. Length of Stay
      • i. Industry Diversification
      • j. Physician Demographics
      • k. Aging Population
        • More Chronic Illness
        • Disease Incidence
        • Susceptibility to latrogenesis
        • Multiple Illnesses Cases
      • l. Laboratory Regulations
    • 2. Market Structure
      • a. Hospitals
      • b. Commercial/Private Laboratories
  • C. Physician Offices/Group Practices
    • 1. Market Summary
    • 2. Market Structure
    • 3. Test Volume and Sales Forecasts
  • D. Ancillary Hospital Locations
    • 1. Introduction
      • a. Emergency Departments
      • b. Operating Suites
      • c. Intensive Care Units
    • 2. Emergency Departments
      • a. Market Summary
      • b. Test volume and Sales Forecasts
    • 3. Operating and Recovery Suites
      • a. Market Summary
      • b. Test Volume and Sales Forecasts
    • 4. ICUs/CCUs
      • a. Market Summary
      • b. Test Volume and Sales Forecasts
  • E. Cancer Clinics
    • 1. Introduction
    • 2. Market Summary
    • 3. Test Volume and Sales Forecasts
  • F. Ambulatory Care Centers
    • 1. Introduction
    • 2. Market Summary
    • 3. Market Structure
    • 4. Test Volume and Sales Forecasts
  • G. Surgery Centers
    • 1. Introduction
    • 2. Market Summary
    • 3. Market Structure
    • 4. Test Volume and Sales Forecasts
  • H. Nursing Homes
    • 1. Introduction
    • 2. Market Summary
    • 3. Market Structure
    • 4. Test Volume and Sales Forecasts
  • I. Birth Centers
    • 1. Introduction
    • 2. Market Summary
    • 3. Market Structure
    • 4. Test Volume and Sales Forecasts
  • J. Major Suppliers' Instrument Placements, Installed Base, Reagent Sales and Market Shares

Germany

  • A. Market Overview
  • B. Market Structure
  • C. Market Summary
  • D. Major Suppliers' Reagent Sales and Market Shares

Spain

  • A. Business Environment
  • B. Market Structure
  • C. Market Summary
  • D. Major Suppliers' Reagent Sales and Market Shares

Major Product Development Opportunities

Design Criteria for Decentralized Testing Products

Alternative Market Penetration Strategies

  • A. Internal Development
  • B. Collaborative Arrangements
  • C. University Contracts
  • D. Distribution Strategies for Decentralized Testing Markets
    • 1. Marketing Approaches
    • 2. Product complexity
    • 3. Customer Preference
    • 4. Established Suppliers
    • 5. Emerging Suppliers
    • 6. Major Types of Distributors
    • 7. Market Segmentation

Potential Market Entry Barriers and Risks

  • A. Market Maturity
  • B. Cost Containment
  • C. Competition
  • D. Technological Edge and Limitations
  • E. Patent Protection
  • F. Regulatory Constraints
  • G. Decentralized Testing Market Challenges

Company Profile

  • Abbott
  • Affymetrix
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • bioMerieux
  • Bio-Rad
  • Cepheid
  • Diamedix
  • DiaSorin
  • Eiken Chemical
  • Enzo Biochem
  • Fujirebio/Innogenetics
  • Grifols/Novartis Diagnostics
  • Hologic/Gen-Probe
  • ID Biomedical/GSK
  • Kreatech
  • Lonza
  • Nanogen/Elitech
  • Ortho-Clinical Diagnostics
  • Qiagen
  • Roche
  • Scienion
  • Sequenom
  • SeraCare
  • Siemens
  • Takara Bio
  • Thermo Fisher/Life Technology
  • Wallac/PE
  • Wako

List of Tables

  • Major Companies Developing or Marketing AIDS Tests
  • Major Companies Developing or Marketing Adenovirus Tests
  • Major Companies Developing or Marketing Campylobacter Tests
  • Major Companies Developing or Marketing Candida Tests
  • Major Companies Developing or Marketing CMV Tests
  • Major Companies Developing or Marketing EBV Tests
  • Major Companies Developing or Marketing Gonorrhea Tests
  • Major Companies Developing or Marketing Helicobacter Pylori Tests
  • Major Companies Developing or Marketing Hepatitis Tests
  • Major Companies Developing or Marketing Herpes Tests
  • Major Companies Developing or Marketing Influenza Tests
  • Major Companies Developing or Marketing Legionella Tests
  • Major Companies Developing or Marketing Lyme Disease Tests
  • Major Companies Developing or Marketing Measles Tests
  • Major Companies Developing or Marketing Meningitis Tests
  • Major Companies Developing or Marketing Mononucleosis Tests
  • Major Companies Developing or Marketing Mumps Tests
  • Major Companies Developing or Marketing Mycoplasma Tests
  • Major Companies Developing or Marketing Pneumonia Tests
  • Major Companies Developing or Marketing RSV Tests
  • Major Companies Developing or Marketing Rotavirus Tests
  • Major Companies Developing or Marketing Rubella Tests
  • Major Companies Developing or Marketing Salmonella Tests
  • Major Companies Developing or Marketing Shigella Tests
  • Major Companies Developing or Marketing Streptococci Tests
  • Major Companies Developing or Marketing Syphilis Tests
  • U.S.A., Physician Office/Group Practice Laboratories Forecast by Practice Size
  • U.S.A., Physician Offices/Group Practices Forecast by Type
  • U.S.A., Office-Based Physicians Forecast by Practice Type
  • U.S.A., Physician Offices/Group Practices Infectious Disease Test Volume Forecast
  • U.S.A., Physician Offices/Group Practices Microbiology Test Volume Forecast
  • U.S.A., Physician Offices/Group Practices Infectious Disease Reagent and Instrument Sales Forecast
  • U.S.A., Physician Offices/Group Practices Microbiology Reagent and Instrument Sales Forecast
  • U.S.A., Ancillary Hospital Locations Estimated Number
  • U.S.A., Ancillary Hospital Locations Annual Utilization
  • U.S.A., Hospital Emergency Departments Infectious Disease Test Volume Forecast
  • U.S.A., Hospital Emergency Departments Infectious Disease Reagent and Instrument Sales Forecast
  • U.S.A., Ambulatory Care Centers Estimated Number of Facilities and Patient Visits
  • U.S.A., Ambulatory Care Centers Most Frequent Diagnoses
  • U.S.A., Ambulatory Care Centers Infectious Disease Test Volume Forecast
  • U.S.A., Ambulatory Care Centers Microbiology And Serology Test Volume Forecast
  • U.S.A., Ambulatory Care Centers Infectious Disease Reagent and Instrument Sales Forecast
  • U.S.A., Ambulatory Care Centers Microbiology and Serology Reagent and Instrument Sales Forecast
  • U.S.A., Surgery Centers Most Frequently Performed Procedures
  • U.S.A., Surgery Centers Microbiology and Serology Test Volume Forecast
  • U.S.A., Surgery Centers Microbiology And Serology Reagent and Instrument Sales Forecast
  • U.S.A., Birth Centers Facilities, Patient Visits, and Births
  • U.S.A., Birth Centers Microbiology and Serology Test Volume Forecast
  • U.S.A., AIDS Testing Market Estimated Market Shares of Major Suppliers
  • U.S.A., Chlamydia Testing Market Estimated Market Shares of Major Suppliers
  • U.S.A., CMV Testing Market Estimated Market Shares of Major Suppliers
  • U.S.A., Gonorrhea Testing Market Estimated Market Shares of Major Suppliers
  • U.S.A., Helicobacter Pylori Testing Market Estimated Market Shares of Major Suppliers
  • U.S.A., Hepatitis Testing Market Estimated Market Shares of Major Suppliers
  • U.S.A., Herpes Testing Market Estimated Market Shares of Major Suppliers
  • U.S.A., Influenza Testing Market Estimated Market Shares of Major Suppliers
  • U.S.A., Lyme Disease Testing Market Estimated Market Shares of Major Suppliers
  • U.S.A., Mononucleosis Testing Market Estimated Market Shares of Major Suppliers
  • U.S.A., Rubella Testing Market Estimated Market Shares of Major Suppliers
  • U.S.A., Streptococci Testing Market Estimated Market Shares of Major Suppliers
  • U.S.A., Syphilis Testing Market Estimated Market Shares of Major Suppliers
  • Germany, Laboratory Performing Diagnostic Tests by Market Segment
  • Germany, AIDS Testing Market Estimated Market Share of Major Suppliers
  • Germany, Gonorrhea Testing Market Estimated Market Share of Major Suppliers
  • Germany, Hepatitis Testing Market Estimated Market Share of Major Suppliers
  • Germany, Herpes Testing Market Estimated Market Share of Major Suppliers
  • Germany, Influenza Testing Market Estimated Market Share of Major Suppliers
  • Germany, Mononucleosis Testing Market Estimated Market Share of Major Suppliers
  • Germany, Septicemia Testing Market Estimated Market Share of Major Suppliers
  • Germany, Streptococci Testing Market Estimated Market Share of Major Suppliers
  • Spain, Laboratory Performing Infectious Disease Tests by Market Segment
  • Spain, AIDS Testing Market Estimated Market Shares of Major Suppliers
  • Spain, Chlamydia Testing Market Estimated Market Shares of Major Suppliers
  • Spain, Hepatitis Testing Market Estimated Market Shares of Major Suppliers
  • Spain, Herpes Testing Market Estimated Market Shares of Major Suppliers
  • Spain, Influenza Testing Market Estimated Market Shares of Major Suppliers
  • Spain, Mononucleosis Testing Market Estimated Market Shares of Major Suppliers
  • Spain, Rubella Testing Market Estimated Market Shares of Major Suppliers
  • Spain, Streptococci Testing Market Estimated Market Shares of Major Suppliers
  • Spain, Syphilis Testing Market Estimated Market Shares of Major Suppliers